Original Research

DOI: 10.4244/EIJ-D-25-00784

Changes in absolute coronary blood flow and myocardial resistance after percutaneous coronary intervention

Federico Marin1,2, MD; Samer Fawaz2,3, BMBS; Rafail A. Kotronias4, MBChB, MSc; Jason Chai1, MBBCh; Jason Walsh1, MBBCh; Thabo Mahendiran5,6, BMBCh, MD; Grigoris V. Karamasis3, MD, MSc; Christopher M. Cook2,3, MBBS, PhD; Sarosh Khan2,3, MBBS; John R. Davies2,3, MBBS, PhD; Carlos Collet5, MD, PhD; Bernard De Bruyne5, MD, PhD; Keith Channon4, MBChB, MD; Adrian P. Banning1, MBChB, MD; Thomas R. Keeble2,3, MBBS, MD; Giovanni Luigi De Maria1, MD, PhD; on behalf of the Oxford Acute Myocardial Infarction (OxAMI) study investigator

Abstract

Background: Treating a coronary stenosis by percutaneous coronary intervention (PCI) aims to relieve myocardial ischaemia by improving coronary blood flow. The evolution of coronary flow and resistance post-PCI is not fully understood.

Aims: This study aimed to investigate the immediate impact of PCI on absolute coronary flow (Q), and epicardial and microvascular resistance (Repi and Rμ).

Methods: In a two-centre cohort including 52 patients, pre- and post-PCI physiological assessments were performed using continuous thermodilution, via a combination of a pressure-temperature sensor wire and a dedicated infusion microcatheter.

Results: Resting Q remained similar before and after PCI (Δ +2 [interquartile range [IQR] −9 to 21] mL/min; p=0.21), as a 193 Wood unit (WU) reduction in resting Repi (Δ −193 [IQR −400 to −59] WU; p<0.001) was offset by a 267 WU increase in resting Rμ (Δ +267 [IQR −20 to 474] WU; p=0.002). Conversely, hyperaemic Q rose significantly (Δ +44 [IQR 16 to 92] mL/min; p<0.001), reflecting a 195 WU reduction in hyperaemic Repi (Δ −195 [IQR −379 to −82] WU; p<0.001), while hyperaemic Rμ remained stable (Δ +3 [IQR −96 to 75] WU; p=0.87). The median microvascular resistance reserve (MRR) did not change significantly after PCI (Δ −0.2 [IQR −0.7 to 0.6]; p=0.301). Pre- and post-PCI fractional flow reserve (FFR) were strongly and inversely associated with Repi and predicted the improvement of hyperaemic Q.

Conclusions: PCI significantly reduces epicardial resistance, leading to a pronounced increase in hyperaemic flow, which can be predicted by FFR. Resting Q remained unchanged because of compensatory increases in microvascular resistance, providing direct evidence of coronary flow autoregulation in humans. The MRR was unaffected by PCI, confirming its specificity as an index of microvascular function.

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 22 Number 5
Mar 2, 2026
Volume 22 Number 5
View full issue


Key metrics

Suggested by Cory

State-of-the-Art Review

10.4244/EIJ-D-20-00988 Apr 2, 2021
Optimising physiological endpoints of percutaneous coronary intervention
Al-Lamee R et al
free

EXPERT REVIEW

10.4244/EIJ-D-17-00503 Aug 25, 2017
State of the art: pressure wire and coronary functional assessment
Echavarria-Pinto M et al
free

10.4244/EIJV17I4A47 Jul 20, 2021
Coronary flow capacity: where to next?
Johnson NP and Gould K
free

Clinical research

10.4244/EIJ-D-23-00026 Aug 7, 2023
Quantitative flow ratio as a continuous predictor of myocardial infarction
Guan C et al
free

Clinical research

10.4244/EIJ-D-18-00913 Aug 29, 2019
Influence of target vessel on prognostic relevance of fractional flow reserve after coronary stenting
Hwang D et al
free
Trending articles
334.8

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
33.05

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
27.6

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
27.6

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved